摘要
Objective: To investigate the expressions of caveolin-1, E-cadherin and β-catenin in gastric carcinoma, precancerous gastric and chronic non-atrophic gastritis tissues, and evaluate the correlation of these expressions with the development of gastric cancer. Methods: The expressions of caveolin-1, E-cadherin and β-catenin were detected by biotin-streptavidinperoxidase (SP) immunohistochemistry on 58 gastric cancer tissues, 40 precancerous gastric tissues and 42 chronic non-atrophic gastritis tissues. The correlation between the expressions of caveolin-1, E-cadherin and β-catenin, and the clinicopathologic parameters of gastric cancer was analyzed retrospectively. Results: The positive rates of caveolin-1 and E-cadherin expressions in gastric carcinoma were significantly lower than precancerous gastric and chronic non-atrophic gastritis tissues (P〈0.01). An abnormal rate of β-catenin expression in gastric carcinoma was higher than precancerous gastric and chronic non-atrophic gastritis tissues (P〈0.01). Moreover, low expressions of caveolin-1, E-cadherin and β-catenin correlated with tumor size, depth of invasion, lymph node metastasis and TNM stage (P〈0.05). The positive rates of caveolin-1 and E-cadherin expressions decreased (P〈0.01), while an abnormal rate of β-catenin expression increased inversely, with the degree of atypical hyperplasia (P〈0.01). Caveolin-1 expression correlated positively with E-cadherin (r=0.41, P〈0.05). Caveolin-1 (r=-0.36, P〈0.05) and E-cadherin (r=-0.45, P〈0.05) expressions negatively correlated with abnormal β-catenin expression. Conclusion: These results suggested that dysregulated expressions of caveolin-1, E-cadherin and β-catenin correlated with the development of gastric cancer and its biological behavior.
Objective: To investigate the expressions of caveolin-1, E-cadherin and β-catenin in gastric carcinoma, precancerous gastric and chronic non-atrophic gastritis tissues, and evaluate the correlation of these expressions with the development of gastric cancer. Methods: The expressions of caveolin-1, E-cadherin and β-catenin were detected by biotin-streptavidinperoxidase (SP) immunohistochemistry on 58 gastric cancer tissues, 40 precancerous gastric tissues and 42 chronic non-atrophic gastritis tissues. The correlation between the expressions of caveolin-1, E-cadherin and β-catenin, and the clinicopathologic parameters of gastric cancer was analyzed retrospectively. Results: The positive rates of caveolin-1 and E-cadherin expressions in gastric carcinoma were significantly lower than precancerous gastric and chronic non-atrophic gastritis tissues (P〈0.01). An abnormal rate of β-catenin expression in gastric carcinoma was higher than precancerous gastric and chronic non-atrophic gastritis tissues (P〈0.01). Moreover, low expressions of caveolin-1, E-cadherin and β-catenin correlated with tumor size, depth of invasion, lymph node metastasis and TNM stage (P〈0.05). The positive rates of caveolin-1 and E-cadherin expressions decreased (P〈0.01), while an abnormal rate of β-catenin expression increased inversely, with the degree of atypical hyperplasia (P〈0.01). Caveolin-1 expression correlated positively with E-cadherin (r=0.41, P〈0.05). Caveolin-1 (r=-0.36, P〈0.05) and E-cadherin (r=-0.45, P〈0.05) expressions negatively correlated with abnormal β-catenin expression. Conclusion: These results suggested that dysregulated expressions of caveolin-1, E-cadherin and β-catenin correlated with the development of gastric cancer and its biological behavior.
基金
supported by Zhejiang Provincial Natural Science Foundation (No. Y206750)
Zhejiang Foundation for Development of Science and Technology, China (No. 2008C33066)
Wenzhou Foundation for Development of Science and Technology,China (No. H20060026)